These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. BIA 10-2474: Some Lessons are Clear but Important Questions Remain Unanswered. Peck RW; Holstein SA; van der Graaf PH Clin Pharmacol Ther; 2022 Feb; 111(2):343-345. PubMed ID: 35007339 [No Abstract] [Full Text] [Related]
69. Reply to Letter: The Use of IC50 for Potency and MTD as Objective in Study BIA 10-2474, by Mattheus van Iersel, MD. Chaikin P J Clin Pharmacol; 2017 Oct; 57(10):1359-1361. PubMed ID: 28815653 [No Abstract] [Full Text] [Related]
71. Antimalarial and antimicrobial activities of 8-Aminoquinoline-Uracils metal complexes. Phopin K; Sinthupoom N; Treeratanapiboon L; Kunwittaya S; Prachayasittikul S; Ruchirawat S; Prachayasittikul V EXCLI J; 2016; 15():144-52. PubMed ID: 27103894 [TBL] [Abstract][Full Text] [Related]
72. The utility of iron chelators in the management of inflammatory disorders. Lehmann C; Islam S; Jarosch S; Zhou J; Hoskin D; Greenshields A; Al-Banna N; Sharawy N; Sczcesniak A; Kelly M; Wafa K; Cheliak W; Holbein B Mediators Inflamm; 2015; 2015():516740. PubMed ID: 25878400 [TBL] [Abstract][Full Text] [Related]
73. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V Drug Des Devel Ther; 2013; 7():1157-78. PubMed ID: 24115839 [TBL] [Abstract][Full Text] [Related]
74. Superinfection in malaria: Plasmodium shows its iron will. Portugal S; Drakesmith H; Mota MM EMBO Rep; 2011 Dec; 12(12):1233-42. PubMed ID: 22081142 [TBL] [Abstract][Full Text] [Related]
75. In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Pradines B; Ramiandrasoa F; Basco LK; Bricard L; Kunesch G; Le Bras J Antimicrob Agents Chemother; 1996 Sep; 40(9):2094-8. PubMed ID: 8878587 [TBL] [Abstract][Full Text] [Related]
76. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330 [TBL] [Abstract][Full Text] [Related]
77. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Nickell SP; Scheibel LW; Cole GA Infect Immun; 1982 Sep; 37(3):1093-100. PubMed ID: 6752020 [TBL] [Abstract][Full Text] [Related]
78. Polyamine oxidase-mediated intraerythrocytic killing of Plasmodium falciparum: evidence against the role of reactive oxygen metabolites. Rzepczyk CM; Saul AJ; Ferrante A Infect Immun; 1984 Jan; 43(1):238-44. PubMed ID: 6360897 [TBL] [Abstract][Full Text] [Related]
79. Deferoxamine inhibition of malaria is independent of host iron status. Hershko C; Peto TE J Exp Med; 1988 Jul; 168(1):375-87. PubMed ID: 3294334 [TBL] [Abstract][Full Text] [Related]